Some research protocols have explored doses up to 4.5 mg weekly, which showed slightly greater efficacy in the phase 2 dose-finding trial but also increased side effect burden
This is a clinical-level guide synthesizing findings from primary scientific literature to provide a definitive resource for the bio-hacker, clinician, and advanced user
Meto's Perspective: What We Think Patients Deserve to Know At Meto, our clinical focus is on metabolic and hormonal health the kind of deep, root-cause medicine that requires real diagnostics, physician oversight, and evidence-based treatment protocols
Fetching molecular profile AHK-CuAlso known as: Alanine-Histidine-Lysine-Copper tripeptide, Copper tripeptide-1, Copper peptide GHK-Cu analogue Mechanism of Action AHK-Cu functions by binding copper ions which facilitates cellular communication and skin repair processes
Changes in gut and plasma microbiome following exercise challenge in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)